167 related articles for article (PubMed ID: 32939016)
1. Testosterone therapy and breast histopathological features in transgender individuals.
Baker GM; Guzman-Arocho YD; Bret-Mounet VC; Torous VF; Schnitt SJ; Tobias AM; Bartlett RA; Fein-Zachary VJ; Collins LC; Wulf GM; Heng YJ
Mod Pathol; 2021 Jan; 34(1):85-94. PubMed ID: 32939016
[TBL] [Abstract][Full Text] [Related]
2. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies.
Chaum M; Grossi S; Chen J; Hu V; Ray E; Giuliano A; Bose S
Breast; 2023 Dec; 72():103596. PubMed ID: 37951051
[TBL] [Abstract][Full Text] [Related]
3. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
4. Establishing a Cohort of Transgender Men and Gender Nonconforming Individuals to Understand the Molecular Impact of Testosterone on Breast Physiology.
Baker GM; Pyle ME; Tobias AM; Bartlett RA; Phillips J; Fein-Zachary VJ; Wulf GM; Heng YJ
Transgend Health; 2019; 4(1):326-330. PubMed ID: 31750394
[No Abstract] [Full Text] [Related]
5. Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals.
Heng YJ; Baker GM; Fein-Zachary VJ; Guzman-Arocho YD; Bret-Mounet VC; Massicott ES; Gitin S; Russo P; Tobias AM; Bartlett RA; Varma G; Kontos D; Yaghjyan L; Irwig MS; Potter JE; Wulf GM
medRxiv; 2024 Jan; ():. PubMed ID: 38260574
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic Features of Breast Tissue From Transgender Men and Their Associations With Androgen Therapy.
Wolters EA; Rabe KE; Siegel L; Butts J; Klein ME
Am J Clin Pathol; 2023 Jan; 159(1):43-52. PubMed ID: 36469057
[TBL] [Abstract][Full Text] [Related]
7. Pathologic Evaluation of Breast Tissue From Transmasculine Individuals Undergoing Gender-Affirming Chest Masculinization.
Hernandez A; Schwartz CJ; Warfield D; Thomas KM; Bluebond-Langner R; Ozerdem U; Darvishian F
Arch Pathol Lab Med; 2020 Jul; 144(7):888-893. PubMed ID: 31816268
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Cancer and Premalignant Lesions in Surgical Specimens of Transgender Patients.
Jacoby A; Rifkin W; Zhao LC; Bluebond-Langner R
Plast Reconstr Surg; 2021 Jan; 147(1):194-198. PubMed ID: 33370065
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Considerations for Safe Gender-Affirming Mastectomy: Preoperative Imaging, Pathologic Evaluation, Counseling, and Long-Term Screening.
Salibian AA; Axelrod DM; Smith JA; Fischer BA; Agarwal C; Bluebond-Langner R
Plast Reconstr Surg; 2021 Feb; 147(2):213e-221e. PubMed ID: 33565823
[TBL] [Abstract][Full Text] [Related]
10. Apocrine ductal carcinoma in situ associated with testosterone therapy in a transgender individual.
Mingrino J; Wang Y
Breast J; 2021 May; 27(5):475-477. PubMed ID: 33547745
[TBL] [Abstract][Full Text] [Related]
11. Implications of testosterone therapy on wound healing and operative outcomes of gender-affirming chest masculinization surgery.
Rysin R; Skorochod R; Wolf Y
J Plast Reconstr Aesthet Surg; 2023 Jun; 81():34-41. PubMed ID: 37084532
[TBL] [Abstract][Full Text] [Related]
12. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
13. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gomez-Lobo V; Gray M
Am J Obstet Gynecol; 2019 Mar; 220(3):257.e1-257.e7. PubMed ID: 30579875
[TBL] [Abstract][Full Text] [Related]
14. Incidence of breakthrough bleeding in transgender and gender-diverse individuals on long-term testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
Am J Obstet Gynecol; 2024 Apr; 230(4):434.e1-434.e10. PubMed ID: 38181830
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic findings in breast surgical specimens from patients undergoing female-to-male gender reassignment surgery.
Torous VF; Schnitt SJ
Mod Pathol; 2019 Mar; 32(3):346-353. PubMed ID: 30310177
[TBL] [Abstract][Full Text] [Related]
16. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
Aubrey C; Saad N; Köbel M; Mattatall F; Nelson G; Glaze S
Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874
[TBL] [Abstract][Full Text] [Related]
17. Gender-affirming hormones and surgery in transgender children and adolescents.
Mahfouda S; Moore JK; Siafarikas A; Hewitt T; Ganti U; Lin A; Zepf FD
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations.
Pamulapati S; Conroy M; Cortina C; Harding E; Kamaraju S
Arch Sex Behav; 2024 May; 53(5):1969-1980. PubMed ID: 38148450
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gray M; Gomez Lobo V
J Sex Med; 2020 Sep; 17(9):1807-1818. PubMed ID: 32703706
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of pelvic pain in transgender individuals on testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
J Sex Med; 2023 Nov; 20(12):1459-1465. PubMed ID: 37837637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
